Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 150 of 484 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/01/22
End: 05/01/27
Due: 05/01/28
Phase: N/A
Priority: Normal
Start: 03/15/23
End: 12/01/24
Due: 12/01/25
Phase: N/A
Priority: Normal
Start: 02/01/24
End: 09/30/28
Due: 09/30/29
Phase: N/A
Priority: Normal
Start: 03/31/12
End: 02/28/14
Due: 02/28/15
Phase: N/A
Priority: Normal
Start: 02/09/23
End: 02/01/26
Due: 02/01/27
Phase: N/A
Priority: Normal
Start: 07/31/16
End: 01/31/17
Due: 01/31/18
Phase: N/A
Priority: Normal
Start: 02/01/21
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 09/20/24
End: 07/01/27
Due: 07/01/28
Phase: N/A
Priority: Normal
Start: 04/30/13
End: 02/28/17
Due: 02/28/18
Phase: N/A
Priority: Normal
Start: 10/31/08
End: 01/31/16
Due: 01/31/17
Phase: N/A
Priority: Normal
Start: 05/15/23
End: 06/30/24
Due: 06/30/25
Phase: N/A
Priority: Normal
Start: 04/01/17
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 07/31/09
End: 06/30/15
Due: 06/30/16
Phase: N/A
Priority: Normal
Start: 12/31/14
End: 11/30/19
Due: 11/30/20
Phase: N/A
Priority: Normal
Start: 09/30/97
End: 02/29/16
Due: 02/28/17
Phase: N/A
Priority: Normal
Start: 01/19/21
End: 09/09/23
Due: 09/09/24
Phase: N/A
Priority: Normal
Start: 02/29/12
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 06/30/15
Due: 06/30/16
Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 Diabetes
Phase: N/A
Priority: Normal
Start: 01/01/23
End: 04/30/24
Due: 04/30/25
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 04/30/16
Due: 04/30/17
Phase: N/A
Priority: Normal
Start: 02/10/20
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 06/05/23
End: 11/01/26
Due: 11/01/27
Phase: N/A
Priority: Normal
Start: 07/13/23
End: 10/01/27
Due: 10/01/28
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 07/31/14
Due: 07/31/15
Phase: N/A
Priority: Normal
Start: 06/30/09
End: 08/31/11
Due: 08/31/12